The Integration Conversation
The Integration Conversation
brom
21: Psychedelic Venture Capital - Interview with Ken Belotsky and Stuart Seidman of Negev Capital
48 minutes Posted Aug 3, 2021 at 11:00 am.
Ken & Stuart’s backgrounds  
what is it like raising money for a Psychedelic Venture Fund?  
what is Negev’s focus?   
how do you do due diligence?   
do novel psychedelics replace the classic psychedelics in the long run?   
what are the developing trends in psychedelics?   
is there too much capital in the space?
0:00
48:17
Download MP3
Show notes
Negev Capital is a VC fund focused on psychedelic medicine.  
In this episode of The Integration Conversation, Ken Belotsky and Stuart Seidman tell us about Negev's founding, its strategy, and what it's like to run a venture fund in the psychedelics space.    
❤️ Help us fund the future of psychedelic medicine at Empath Ventures: https://www.empath.vc 
⭐️ Become an Integration Insider and get early access to episodes: https://patreon.com/theintegrationco 
🐦 brom on twitter:  
https://twitter.com/therealbrom 
🎇 Clips and other stuff on Instagram:  
https://instagram.com/theintegrationco 
⏰ Timestamps: